Abbott Labs INC (ABT) Stock Rose While Campbell Newman Asset Management INC Has Lifted Holding by $7.83 Million

September 8, 2018 - By Carolyn Hewitt

Abbott Laboratories (NYSE:ABT) LogoInvestors sentiment decreased to 0.83 in 2018 Q1. Its down 0.08, from 0.91 in 2017Q4. It is negative, as 44 investors sold ABT shares while 606 reduced holdings. 126 funds opened positions while 411 raised stakes. 1.22 billion shares or 0.54% more from 1.22 billion shares in 2017Q4 were reported. Btr Capital Mngmt holds 1.62% or 135,121 shares in its portfolio. Murphy Cap Mngmt stated it has 24,107 shares. Lau Associates Ltd Liability Com invested in 9,109 shares or 0.42% of the stock. Oxbow Advsr Ltd Liability Corp has 0.09% invested in Abbott Laboratories (NYSE:ABT). Trustco Bancshares N Y reported 36,645 shares or 2.23% of all its holdings. Edgewood Mngmt Lc invested 0.02% in Abbott Laboratories (NYSE:ABT). D Scott Neal invested in 0.05% or 1,453 shares. Wheatland Advsr has 0.35% invested in Abbott Laboratories (NYSE:ABT). The Florida-based State Board Of Administration Of Florida Retirement has invested 0.39% in Abbott Laboratories (NYSE:ABT). Moreover, First Quadrant LP Ca has 0.03% invested in Abbott Laboratories (NYSE:ABT). Bbr Ltd holds 0.07% of its portfolio in Abbott Laboratories (NYSE:ABT) for 6,701 shares. Monroe Bankshares Mi holds 0.02% of its portfolio in Abbott Laboratories (NYSE:ABT) for 1,250 shares. Iowa Commercial Bank accumulated 30,801 shares or 0.9% of the stock. Old Dominion Cap Management invested 0.31% of its portfolio in Abbott Laboratories (NYSE:ABT). Baker Ellis Asset Mngmt Limited Liability Company has 15,340 shares for 0.24% of their portfolio.

Since March 7, 2018, it had 0 buys, and 9 insider sales for $10.53 million activity. 64,268 shares were sold by Contreras Jaime, worth $4.30 million on Wednesday, August 29. PEDERSON MICHAEL J had sold 1,050 shares worth $66,601. 8,262 shares were sold by BIRD ROGER, worth $518,450. $125,909 worth of Abbott Laboratories (NYSE:ABT) was sold by Bracken Sharon J on Friday, May 4. Shares for $4.22 million were sold by CAPEK JOHN M on Wednesday, July 25. 9,097 shares were sold by LANE ANDREW H, worth $610,513.

Campbell Newman Asset Management Inc increased its stake in Abbott Labs Inc. (ABT) by 1336.72% based on its latest 2018Q1 regulatory filing with the SEC. Campbell Newman Asset Management Inc bought 132,723 shares as the company’s stock rose 3.04% while stock markets declined. The institutional investor held 142,652 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $8.55 million, up from 9,929 at the end of the previous reported quarter. Campbell Newman Asset Management Inc who had been investing in Abbott Labs Inc. for a number of months, seems to be bullish on the $116.15 billion market cap company. The stock increased 0.58% or $0.38 during the last trading session, reaching $66.21. About 4.06 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 41.91% since September 8, 2017 and is uptrending. It has outperformed by 29.34% the S&P500.

Another recent and important Abbott Laboratories (NYSE:ABT) news was published by Seekingalpha.com which published an article titled: “Buy United Parcel Service – Cramer’s Lightning Round (9/6/18)” on September 07, 2018.

Abbott Laboratories (NYSE:ABT) Ratings Coverage

Among 4 analysts covering Abbott Labs (NYSE:ABT), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Abbott Labs had 4 analyst reports since April 18, 2018 according to SRatingsIntel. The stock of Abbott Laboratories (NYSE:ABT) has “Buy” rating given on Wednesday, April 18 by Jefferies. Citigroup maintained Abbott Laboratories (NYSE:ABT) on Tuesday, April 24 with “Neutral” rating. The stock has “Buy” rating by Stifel Nicolaus on Thursday, July 19.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.